Performance evaluation of a particle-enhanced turbidimetric cystatin C assay on the Hitachi 917 analyzer

被引:12
|
作者
Al-Turkmani, M. Rabie
Law, Terence
Kellogg, Mark D. [1 ]
机构
[1] Childrens Hosp, Dept Lab Med, Boston, MA 02115 USA
关键词
Cystatin C; Turbidimetric; Immunoassay; Method evaluation;
D O I
10.1016/j.cca.2008.08.016
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Human cystatin C is a low molecular weight protein that has been proposed as a new endogenous marker of glomerular filtration rate. We investigated the performance of the Genzyme cystatin C assay on the Hitachi 917 analyzer. Methods: Imprecision. linearity. recovery, and interference studies were performed on the Hitachi 917 analyzer. For method comparison, split sample aliquots were assayed using the described method and 2 other commercially available cystatin C assays. Results: The assay was linear from 0.24 to 6.36 mg/l. Within-run coefficient of variation (CV) was 4.2 and 0.8% at cystatin C concentrations of 0.50 and 2.00 mg/l, respectively. Between-run CV was 4.3 and 2.7% at the same concentrations. The average analytical recovery was 99%. Bilirubin (<= 30 mg/dl), triglycerides (<= 1000 mg/dl), intralipid (L index <= 1000), and rheumatoid factor (<= 1000 IU/ml) did not interfere with the assay. A > 10% change in cystatin C level was observed when hemoglobin concentration was > 800 mg/dl. The assay compared well with the Dade Behring immunonephelometric assay and the Dako immunoturbidimetric assay. Conclusion: The Genzyme cystatin C immunoassay is an acceptable method for the determination of cystatin C on the Hitachi 917 analyzer. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:75 / 77
页数:3
相关论文
共 50 条
  • [31] Evaluation of QMS Everolimus Assay Using Hitachi 917 Analyzer: Comparison With Liquid Chromatography/Mass Spectrometry
    Dasgupta, Amitava
    Davis, Bonnet
    Chow, Loretta
    THERAPEUTIC DRUG MONITORING, 2011, 33 (02) : 149 - 154
  • [32] Evaluation of a homogeneous high density lipoprotein-cholesterol (HDL-C) assay on the Boehringer Mannheim Hitachi 917 (BM/H 917) analyzer.
    Donnelly, JG
    Black, H
    Ooi, DS
    CLINICAL CHEMISTRY, 1997, 43 : 749 - 749
  • [33] Particle-enhanced turbidimetric immunoassay for determination of serum neutrophil gelatinase-associated lipocalin on the Roche Cobas c501 analyzer
    Xiang, Daijun
    Zhang, Hongrui
    Bai, Jie
    Ma, Junlong
    Li, Mianyang
    Gao, Wen
    Zhang, Xiaorui
    Gao, Jimin
    Wang, Chengbin
    CLINICAL BIOCHEMISTRY, 2013, 46 (16-17) : 1756 - 1760
  • [34] Clinical evaluation of TDM assays on the BM/Hitachi 917 analyzer.
    Fitzmaurice, TF
    Zhou, F
    Brough, T
    Yeo, KTJ
    CLINICAL CHEMISTRY, 1998, 44 : A90 - A90
  • [35] Performance characteristics of urine chemistries on the BM/Hitachi 917 Analyzer.
    Rae, P
    Haas, R
    Lipke, D
    Masters, B
    CLINICAL CHEMISTRY, 1996, 42 (06) : 214 - 214
  • [36] Evaluation of an assay for serum 1,5-anhydroglucitol (GlycoMark™) and determination of reference intervals on the Hitachi 917 analyzer
    Nowatzke, W
    Sarno, MJ
    Birch, NC
    Stickle, DF
    Eden, T
    Cole, TG
    CLINICA CHIMICA ACTA, 2004, 350 (1-2) : 201 - 209
  • [37] Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the behring nephelometer systems (BNA, BN II)
    Finney, H
    Newman, DJ
    Gruber, W
    Merle, P
    Price, CP
    CLINICAL CHEMISTRY, 1997, 43 (06) : 1016 - 1022
  • [38] The Emit 2000 tacrolimus assay on the Hitachi 917 analyzer-comparison to LCMS/MS
    LeGatt, D
    Shalapay, C
    THERAPEUTIC DRUG MONITORING, 2005, 27 (02) : 249 - 249
  • [39] Evaluation of Roche Online® assay performance for drugs of abuse screening in urine on Hitachi 917 compared with Hitachi 717.
    Chang, J
    Hoke, C
    CLINICAL CHEMISTRY, 1999, 45 (06) : A120 - A120
  • [40] Analytic and clinical validation of a standardized cystatin C particle enhanced turbidimetric assay (PETIA) to estimate glomerular filtration rate
    Voskoboev, Nikolay V.
    Larson, Timothy S.
    Rule, Andrew D.
    Lieske, John C.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2012, 50 (09) : 1591 - 1596